Does the quadrivalent human papillomavirus (HPV) vaccine prevent cervical cancer, vaginal cancer, vulvar cancer, and genital warts?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

The Quadrivalent HPV Vaccine: Comprehensive Protection

E) All of the above - The quadrivalent HPV vaccine prevents cervical cancer, vaginal cancer, vulvar cancer, and genital warts. 1

Evidence-Based Protection Profile

The quadrivalent HPV vaccine (Gardasil) targets HPV types 6,11,16, and 18, providing protection across multiple disease endpoints:

Cancer Prevention

The vaccine demonstrates high efficacy in preventing precursor lesions that lead to invasive cancers:

  • Cervical cancer precursors: Clinical trials show the vaccine has high efficacy in preventing persistent HPV infection and cervical cancer precursor lesions (CIN 2/3) caused by HPV types 16 and 18, which account for approximately 70% of cervical cancers worldwide 1

  • Vaginal and vulvar cancer precursors: The vaccine was specifically licensed for prevention of vaginal and vulvar cancer precursors (VaIN and VIN) related to vaccine HPV types 1. Recent systematic review data confirms 100% efficacy against HPV 16/18-related VIN/VaIN in per-protocol populations, with 71% efficacy in intention-to-treat analyses 2

  • Real-world cancer prevention: Population-level data demonstrates decreased incidence of vulvar and vaginal cancers following vaccination, particularly among younger women 2

Genital Warts Prevention

The vaccine provides robust protection against genital warts through coverage of HPV types 6 and 11:

  • These low-risk HPV types cause approximately 90% of genital warts cases 3
  • The vaccine prevents anogenital warts in both females and males 1
  • Clinical trials demonstrated 96-100% efficacy in preventing genital warts caused by vaccine HPV types 3

Mechanism of Protection

The vaccine works by preventing persistent infection with the four targeted HPV types among individuals not previously infected with those specific types. Critically, the vaccine provides no protection against HPV types with which individuals are already infected at the time of vaccination 1. However, those infected with one or more vaccine HPV types before vaccination remain protected against disease caused by the other vaccine HPV types 1.

Clinical Efficacy Data

In per-protocol analyses (individuals who received all 3 doses and had no evidence of infection with relevant vaccine HPV types through 1 month after dose 3), the vaccine demonstrated:

  • 99% efficacy for preventing CIN grades II and III caused by HPV 16 or 18 after 3 years 4
  • High efficacy in preventing persistent HPV infection, cervical cancer precursor lesions, vaginal and vulvar cancer precursor lesions, and genital warts 1

Important Caveats

Vaccination does not eliminate the need for cervical cancer screening because not all HPV types that cause cervical cancer are included in the vaccine 1. Vaccinated individuals should continue routine cervical cancer screening as recommended.

The vaccine is most effective when administered before sexual activity begins, which is why routine vaccination is recommended for 11-12 year olds, with catch-up vaccination for those aged 13-26 years who have not been previously vaccinated 1.

References

3
Research

Quadrivalent human papillomavirus vaccine.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2007

4
Guideline

cervical cancer screening.

Journal of the National Comprehensive Cancer Network : JNCCN, 2010

Related Questions

Which human papillomavirus (HPV) strains are covered by the Gardasil (quadrivalent HPV) vaccine?
What is the recommended administration route, dosage, and schedule for the HPV vaccine (Gardasil 9) in different age groups?
Can I receive the human papillomavirus (HPV) vaccine while I have a mild cold?
Is HPV vaccination recommended for a healthy 20‑year‑old male who has not been previously vaccinated, and what is the appropriate dosing schedule?
In a 31-year-old woman who completed the three-dose human papillomavirus (HPV) vaccine series at ages 16 and 17, is there any indication for a fourth HPV vaccine dose?
What specific concern or symptom do you have regarding the clitoris (e.g., pain, swelling, sexual function, hormonal changes, injury)?
What are the drug interactions between venlafaxine, paracetamol, tramadol, and pregabalin?
When is radioactive iodine (RAI) recommended for differentiated thyroid cancer?
What is the appropriate management for a severely dilated right ventricle?
What is the most likely diagnosis for a diabetic patient presenting with bilateral foot numbness and difficulty walking?
Can elevated right ventricular systolic pressure be caused by obstructive sleep apnea?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.